Released on 2025-05-13
203167 Phase 2a in Psoriasis
Accession number
ELU-2-B13148-1
Description
Psoriasis Phase 2a clinical study. PLSS, PASI, and PGA longitudinal data of all placebo subjects. Histology data of lesional biopsies from placebo subjects at days 1 and 43. Transcriptomic data of lesional biopsies and whole blood from placebo subjects at days 1 and 43.
- Project Title
- ImmUniverse
- Project website
- https://www.immuniverse.eu
- Study title
- 203167 Phase 2a in Psoriasis
- Version
- V1.0
- Created on
- 2025-02-26
- Updated on
- 2025-02-26
- Experiment types
- Transcriptome array clinical data RNASeq
- Type of Samples Collected
- Blood Tissue
- Number of Samples Collected
- 36 blood samples and 54 biopsies
- Data owner
- -
- Main contact
- Sumanta Mukherjee
- Sumanta.8.mukherjee@gsk.com
- Affiliation
- GlaxoSmithKline
info Constrained permissions
| Use Restriction | Remarks | Category (GA4GH) |
|---|---|---|
| For ImmUniverse consortium only | Use of DATA is limited to the RESEARCH PROJECT. Is the use of data limited to the project named in the Submission sheet? | Project-Specific restrictions (PS) |
thumb_up Permissions
| Use Restriction | Remarks | Category (GA4GH) |
|---|---|---|
| There is not requirement to return data. | Data return requirements Is there a requirement to return data or documents to the database/resource? | Return data to database/resource (RTN) |
hardware Obligations
| Use Restriction | Remarks | Category (GA4GH) |
|---|---|---|
| Publication must include disclosure of conflicts of interest, citation of the cohort and reference to ethical committee agreement. | Publication requirements Are there any requirements in case of publications based on the DATA? E.g. papers should cite the cohort study. | Publication Required (PUB) |
